Business

Guardian Pharmacy Services, Inc. Reports First Quarter 2025 Financial Results

ATLANTA, May 12, 2025--Guardian Pharmacy Services, Inc. ("Guardian") (NYSE: GRDN), one of the nation’s largest long-term care (LTC) pharmacy services companies, today announced financial results for the first quarter ended March 31, 2025.

articleGuardian Pharmacy Services, Inc.May 12, 202515/company/guardian-pharmacy-services-inc/news/guardian-pharmacy-services-inc-reports-200500877
Guardian Pharmacy Services, Inc. Reports First Quarter 2025 Financial Results

About this update from Guardian Pharmacy Services, Inc.

[{"type":"text","content":"ATLANTA, May 12, 2025--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. ("Guardian") (NYSE: GRDN), one of the nation’s largest long-term care (LTC) pharmacy services companies, today announced financial results for the first quarter ended March 31, 2025.","length":265,"tagName":"p"},{"type":"text","content":"First Quarter 2025 Highlights","length":29,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue of $329.3 million, an increase of 20% year-over-year, driven by organic growth and the previously announced acquisitions of Heartland Pharmacy on April 1, 2024 and Freedom Pharmacy on November 1, 2024 (the "acquisitions").","length":240,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":240,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Resident Count of 189,000 at the end of the quarter, an increase of 15% year-over-year and up from 186,000 at December 31, 2024, attributable to organic growth and the acquisitions.","length":181,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":181,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Net Income of $9.3 million, an increase of $2.2 million year-over-year. 1","length":73,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":73,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Adjusted EBITDA of $23.4 million, an increase of 16% year-over-year, after the impact of approximately $1.0 million of costs to operate as a public company.2","length":157,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":157,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Cash and cash equivalents at the end of the period was $14.0 million with no long-term debt outstanding.","length":104,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":104,"olType":false},{"type":"text","content":"Commenting on the quarter, Fred Burke, President & CEO of Guardian, said, "We are pleased to report a strong start to 2025, marked by robust momentum in the first quarter which we believe positions us well for the remainder of the year. We delivered double-digit year-over-year growth in revenue, resident count, and adjusted EBITDA. In addition, we closed a smal...

More updates from Guardian Pharmacy Services, Inc.

GuardianNet IncomeFreedom Pharmacy